References
- Cosman F, Lindsay R. Selective estrogen receptor modulators: Clinical spectrum. Endocr Rev 1999; 20: 418–434
- Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997; 389: 753–758
- Lonard DM, Smith CL. Molecular perspectives on selective estrogen receptor modulators (SERMs): Progress in understanding their tissue-specific agonist and antagonist actions. Steroids 2002; 67: 15–24
- Jayachandran M, Miller VM. Human platelets contain estrogen receptor alpha, caveolin-1 and estrogen receptor associated proteins. Platelets 2003; 14: 75–81
- Khetawat G, Faraday N, Nealen ML, Vijayan KV, Bolton E, Noga SJ, Bray PF. Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): Testosterone regulates AR expression. Blood 2000; 95: 2289–2296
- Azevedo GD, Franco RF, Baggio MS, Maranhao TM, Ferriani RA, Silva de Sa MF. Effects of raloxifene therapy on the anticoagulant system in postmenopausal women. Climacteric 2003; 6: 140–145
- Cosman F, Baz-Hecht M, Cushman M, Vardy MD, Cruz JD, Nieves JW, et al. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: A randomized-controlled study and review of the literature. Thromb Res 2005; 116: 1–13
- Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. Description of an in vitro platelet function analyzer-PFA-100. Semin Thromb Hemost 1995; 21(Suppl 2)106–112
- Franchini M. The platelet function analyzer (PFA-100): An update on its clinical use. Clin Lab 2005; 51: 367–372
- Jayachandran M, Mukherjee R, Steinkamp T, LaBreche P, Bracamonte MP, Okano H, et al. Differential effects of 17beta-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation, and secretion in platelets. Am J Physiol Heart Circ Physiol 2005; 288: 2355–2362
- O’Lone R, Frith MC, Karlsson EK, Hansen U. Genomic targets of nuclear estrogen receptors. Mol Endocrinol 2004; 18: 1859–1875
- Nilsson S, Koehler KF. Oestrogen receptors and selective oestrogen receptor modulators: Molecular and cellular pharmacology. Basic Clin Pharmacol Toxicol 2005; 96: 15–25